Abstract
Advances in the development of anticancer agents have led to improvements in survival and quality of life in cancer patients, with a concomitant decrease in many toxicities. However, many agents are still associated with a spectrum of dermatologic adverse events (AE). In this chapter we review the most frequent and clinically significant dermatologic AE associated with the use of anticancer agents for the treatment of dermatologic malignancies. It is critical for dermatologists to understand AE associated with anticancer agents to ensure optimal patient care. A primary goal for the dermatologist should be to manage the AE so that drug therapy can continue when it is showing efficacy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
